Mar 09, 2004 - 4:19 pm
I receive a wonderfully informative newsletter each week from a former researcher with Memorial Sloan-Kettering. These past few weeks he has been focusing on Colorectal drug treatments and their effectiveness. If I were more computer savvy I would just cut and paste it over here....but alas I am not. Nanuk tried to help but well....
So I am just going to highligh a few quotes and anyone who is interested in the whole article(s) please feel free to email me on my ACS addy and give me your home email and I will send it along. I assume you can read it yourself at his website www.cancerdecisions.com. But if not let me know.
"Erbitux has....limited effectiveness not proven to increase cancer patients survival time.
....acne-like rash in 90% of patients....serious to severe in 12%
...73% exhibited weakness and malaise
....inflammator or infectious conditions especially of the eyes were seen.
...Interstitial Lung Disease (ILD) has also been reported. This is a condition that occurs when the lungs become inelastic due to scarring of the tissue between the air sacs. (similar reaction in Iressa led to withdrawal in Japan)....."
This is the drug deal that Martha Stewart was convicted of insider trading stuff. It was touted but from what I read it's mostly fluff.....as with everything...follow the money.
This week he is discussing Avastin. ....another one to do your research on before accepting what they tell you.....and not from the company but read it from someone who has nothing to gain personally or financially from the "slanted" info.
peace, emily who continues to look for answers